百岁老人住院的趋势和临床复杂性:西班牙 (2004-2020) 全国基于人口的研究
Juan Carlos Piñeiro-Fernández1, Ramón Rabuñal-Rey2, Eva Romay-Lema2
1Department of Internal Medicine, Lucus Augusti University Hospital, SERGAS, 1 Ulises Romero Street, 27003, Lugo, Spain. juan.carlos.pineiro.fernandez@udc.es.
European geriatric medicine
|November 25, 2025
概括
在西班牙,百岁老人的住院病例显示出临床复杂性和并发症的增加,主要原因是感染. 医疗保健模式必须适应这个日益增长的脆弱人口.
科学领域:
- 老年医学 老年医学
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 百岁老人代表了一个快速增长的人口.
- 了解这一群体的住院趋势对于医疗保健规划至关重要.
研究的目的:
- 分析西班牙百岁老人入院的临床复杂性,诊断和结果的全国趋势 (2004-2020年).
主要方法:
- 以西班牙国家医院出院数据库为基础的回顾性,基于人口的研究.
- 在三个时期 (2004-2010,2011-2015,2016-2020) 中分析了100岁以上患者的意外入院情况.
- 结点回归模型评估了并发症,诊断,并发症,死亡率和停留时间 (LOS) 的趋势.
主要成果:
- 严重的并发症和多发症显著增加,以及痴呆症和脆弱性相关疾病.
- 感染,特别是呼吸道和尿道感染,成为主要的入院原因.
- 住院并发症增加,多重并发症患者的数量显著增加.
- 住院死亡率略有上升,而平均LOS下降.
- 退院到养老院的人数增加.
结论:
- 百岁老人住院的情况呈现出越来越复杂的临床复杂性和并发症,由感染驱动.
- 尽管停留时间较短,但死亡率略有增加.
- 医疗保健系统需要适应,以满足这个老龄化和脆弱人口的需求.
相关概念视频
Pharmacodynamics in Geriatric Patients: Effects of Age
180
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
180
Current Trends in Nursing I
5.2K
Current trends in nursing include:
5.2K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
217
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
217
Drug Dosing: Geriatric Patients
214
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
214
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
212
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
212
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
186
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
186


